- Home
- SHOP vs NVO Comparison
SHOP vs NVO Comparison
Compare SHOP & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHOP | NVO |
|---|---|---|
| Founded | 2004 | 1923 |
| Country | Canada | Denmark |
| Employees | N/A | 69500 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.5B | 197.4B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHOP | NVO |
|---|---|---|
| Price | $108.48 | $42.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 33 | 11 |
| Target Price | ★ $164.44 | $51.00 |
| AVG Volume (30 Days) | 7.7M | ★ 10.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,556,000,000.00 | N/A |
| Revenue This Year | $29.34 | N/A |
| Revenue Next Year | $23.77 | $3.70 |
| P/E Ratio | ★ N/A | $13.60 |
| Revenue Growth | ★ 30.14 | N/A |
| 52 Week Low | $94.00 | $35.12 |
| 52 Week High | $182.19 | $71.80 |
Technical Indicators
Market Signals| Indicator | SHOP | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 47.21 |
| Support Level | $108.12 | $41.05 |
| Resistance Level | $128.90 | $50.30 |
| Average True Range (ATR) | 5.13 | 1.37 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 23.11 | 43.74 |
Price Performance
Historical ComparisonAbout SHOP Shopify Inc.
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.